Area of research
Genetics · Molecular Biology
Research interest
Research interests include Virus-based gene therapy research, CAR-T cell therapy research, Viral Infectious Diseases and Gene Expression in Insects, and RNA Interference and Gene Delivery.
Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma.
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates.
Mucosal vaccine-induced cross-reactive CD8<sup>+</sup> T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Nonreciprocity in CHIKV and MAYV Vaccine-Elicited Protection.
Author Correction: Mucosal vaccine-induced cross-reactive CD8<sup>+</sup> T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin<sup>®</sup>).
Synthetic Biology Design as a Paradigm Shift toward Manufacturing Affordable Adeno-Associated Virus Gene Therapies
Synthetic Biology Design as a Paradigm Shift toward Manufacturing Affordable Adeno-Associated Virus Gene Therapies.
Adenoviral vectors infect B lymphocytes in vivo
In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer.
In <em>Vitro</em> and In<em> Vivo</em> Efficacy of a Stroma Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer
Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation.
Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation
Supplementary Figure 1 from Combined Transductional Untargeting/Retargeting and Transcriptional Restriction Enhances Adenovirus Gene Targeting and Therapy for Hepatic Colorectal Cancer Tumors
Supplementary Figures S1-S18 from Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
Data from Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface.
A Novel Piggyback Strategy for mRNA Delivery Exploiting Adenovirus Entry Biology.
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic.
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
The NIH Somatic Cell Genome Editing program
Understanding and addressing barriers to successful adenovirus-based virotherapy for ovarian cancer.
Synthetic Biology Approaches for Engineering Next-Generation Adenoviral Gene Therapies.
Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients
Mucopolysaccharidoses type I gene therapy.
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors.
Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents.
Evaluation of tumor immunity after administration of conditionally replicative adenoviral vector in canine osteosarcoma patients